News & Trends - Biotechnology

Purpose, policy and the future of clinical trials: Noxopharm CEO on what’s next for Australian biotech

As the world marks Clinical Trials Day (20 May), Dr Gisela Mautner, CEO of ASX-listed biotech Noxopharm, brings a bold […]

News & Trends - Biotechnology

World-first trial 3D prints skin directly onto wounds using robotic technology

In a world-first clinical trial, a robot developed by an Australian biotech company is being used to 3D print human […]

News & Trends - Biotechnology

Immunotherapy combo doubles survival in hard-to-treat head and neck cancer, challenging standard of care

An ASX-listed biotech has released new survival data demonstrating the potential of its novel immunotherapy combination in first-line recurrent or […]

News & Trends - Biotechnology

Government backs industry and research partners in regenerative therapy manufacturing

Australia’s push to lead in regenerative therapy manufacturing has taken a major leap forward with the federal government announcing $65 […]

News & Trends - Biotechnology

Local biotech kicks off phase 3 trial for lung cancer combination therapy

ASX-listed biotech company Immutep has reached a major milestone, announcing that the first patient has been successfully dosed in its […]

News & Trends - Biotechnology

Aussie biotech announces R&D partnership for first in-human trial in lupus

ASX listed biotech company Noxopharm has engaged a highly-regarded Australian phase 1 unit to deliver the upcoming HERACLES clinical trial. […]

News & Trends - Biotechnology

AusBiotech and Medicines Australia IWD luncheon: A collective voice for bold action on gender equity

AusBiotech and Medicines Australia are joining forces to host the highly anticipated annual Women in Life Sciences luncheon, set to […]

News & Trends - Biotechnology

Breaking the silence on lupus: Industry, MPs and patients unite to tackle the critical gaps

Medicines Australia, AstraZeneca, and Noxopharm joined the Parliamentary Friends of Autoimmune Diseases event, spearheaded by the patient advocacy group Dragon […]

News & Trends - Biotechnology

Aussie biotech leads world-first combination trial in aggressive breast cancer

A world-first clinical trial is set to explore a promising new combination therapy for triple-negative breast cancer, one of the […]

News & Trends - Biotechnology

Australia’s largest biotech secures first TGA listing for HAE rare disease

The Therapeutic Goods Administration (TGA) has granted approval for the registration of the first treatment targeting factor XIIa, offering new […]